Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

Myanmar sentences 2 to death in killing of Suu Kyi aide

Feb 16, 2019

YANGON, Myanmar — A court in Myanmar sentenced two men to death on Friday for the killing of a prominent Muslim lawyer who was a close adviser to the country's leader, Aung San Suu Kyi. The Yangon Northern District Court found Kyi Lin guilty of premeditated murder and illegal weapons possession in the Jan. 29, 2017, shooting of Ko Ni at Yangon's airport. It also sentenced to death another man for helping to plan the killing, and gave prison sentences to two other men it said were also involved in the crime. A fifth suspect accused of being the mastermind...

Thai princess' political bid sunk by her brother, the king

Feb 16, 2019

BANGKOK — Thailand's chaotic politics took two astonishing turns Friday when the sister of the king made a historic bid to become prime minister, only to have him shut down her effort as "inappropriate" because it violated tradition and the constitution, which keep the monarchy from getting involved in politics. The royal order from King Maha Vajiralongkorn was read on national television late Friday night, effectively scuttling the move by his older sister, Princess Ubolratana Mahidol, to become a candidate for the prime minister's office after parliamentary elections scheduled for March 24. It was the latest event to roil Thailand,...

Thai princess finds tumult in politics, like life

Feb 16, 2019

BANGKOK — Princess Ubolratana Mahidol, the first child of Thailand's beloved late king, has always been a bit of a rebel, and on Friday she shook Thai society by becoming the first member of the royal family to say she would enter party politics. But hours later, her younger brother, King Maha Vajiralongkorn, commanded her to halt her bid to become prime minister, saying in an order read on television that no member of the royal family should be involved in politics. It wasn't the first unexpected turn in a somewhat turbulent life. Ubolratana, 67, was born into royalty but...

Philippine official: Abu Sayyaf harboring suicide bomber

Feb 16, 2019

MANILA, Philippines — An Abu Sayyaf militant leader accused of plotting a recent suicide attack in a Roman Catholic cathedral in the southern Philippines may be harboring a foreign would-be suicide bomber in his jungle base, a senior official said Thursday. Interior Secretary Eduardo Ano said Abu Sayyaf commander Hatib Hajan Sawadjaan, who allegedly plotted the Jan. 27 attack at Our Lady of Mount Carmel Cathedral on Jolo island that killed 23 people, was also behind a suicide attack last year that killed 11 people in nearby Basilan province. Sawadjaan's goal was to assert his new role as Islamic State...

Philippine police: 5 church bombing suspects in custody

Feb 16, 2019

MANILA, Philippines — Five suspected Abu Sayyaf militants accused of involvement in a deadly suicide attack at a Roman Catholic cathedral in the southern Philippines have surrendered to authorities, the national police chief said Monday amid renewed terrorism fears. Complaints for murder and attempted murder were filed against the five, as well as several other suspected Abu Sayyaf fighters who remain at large, for their alleged role in the Jan. 27 attack at Our Lady of Mount Carmel Cathedral in Sulu province's Jolo town which killed 23 people and wounded nearly 100 others. Before the bombing, the detained suspects escorted...

Sign up now!